National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 10/8/2021 release of VAERS data:

Found 701 cases where Vaccine targets COVID-19 (COVID19) and Manufacturer is JANSSEN and Write-up contains 'thrombosis'



Case Details

This is page 19 out of 71

Result pages: prev   10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28   next


VAERS ID: 1276466 (history)  
Form: Version 2.0  
Age: 59.0  
Sex: Female  
Location: Texas  
Vaccinated:0000-00-00
Onset:2021-04-01
Submitted: 0000-00-00
Entered: 2021-05-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 1808980 / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Abdominal pain, Blood pressure increased, Cardiovascular disorder, Computerised tomogram, Facial discomfort, Headache, Hypoaesthesia, Injection site pain, Laboratory test, Muscular weakness, Neck pain, Peripheral coldness, Urine abnormality, Vasodilatation, Weight decreased
SMQs:, Rhabdomyolysis/myopathy (broad), Acute pancreatitis (broad), Peripheral neuropathy (broad), Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Retroperitoneal fibrosis (broad), Guillain-Barre syndrome (broad), Noninfectious encephalopathy/delirium (broad), Extravasation events (injections, infusions and implants) (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Hypertension (narrow), Cardiomyopathy (broad), Arthritis (broad), Proteinuria (broad), Sexual dysfunction (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness: Raynauds (For which she uses Blood pressure medication.)
Preexisting Conditions: Comments: The patient had no known allergies.
Allergies:
Diagnostic Lab Data: Test Date: 20210419; Test Name: Laboratory test; Result Unstructured Data: No thrombosis finding; Test Date: 20210419; Test Name: CT scan; Result Unstructured Data: No thrombosis findings
CDC Split Type: USJNJFOC20210449661

Write-up: WEAK AND HEAVY FEELING ON THE FACE; FEELS LIKE THE CIRCULATION IS LOW; WEAKNESS ON THE RIGHT LEG RIGHT ARM AND LEFT FOOT; NUMBNESS ON THE RIGHT LEG RIGHT ARM AND LEFT FOOT; COLD LIMBS; ABDOMINAL PAIN; SORE INJECTION SITE; HEADACHE; NECK PAIN; CLOUDY CLEAR URINE; SWOLLEN VEIN ON RIGHT FOOT; HIGHER BP THAN NORMAL; WEIGHT LOSS; This spontaneous report received from a patient concerned a 59 year old female. The patient''s height, and weight were not reported. The patient''s concurrent conditions included raynaud, and other pre-existing medical conditions included the patient had no known allergies.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808980, expiry: UNKNOWN) dose was not reported, administered on 03-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced abdominal pain. On APR-2021, the subject experienced neck pain. On APR-2021, the subject experienced cloudy clear urine. On APR-2021, the subject experienced swollen vein on right foot. On APR-2021, the subject experienced higher bp than normal. On APR-2021, the subject experienced weight loss. On APR-2021, the subject experienced sore injection site. On APR-2021, the subject experienced headache. On 14-APR-2021, the subject experienced numbness on the right leg right arm and left foot. On 14-APR-2021, the subject experienced cold limbs. On 14-APR-2021, the subject experienced weak and heavy feeling on the face. On 14-APR-2021, the subject experienced feels like the circulation is low. On 14-APR-2021, the subject experienced weakness on the right leg right arm and left foot. On 19-APR-2021, Laboratory data included: CT scan (NR: not provided) No thrombosis findings, and Laboratory test (NR: not provided) No thrombosis finding. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from headache, neck pain, sore injection site, numbness on the right leg right arm and left foot, cold limbs, cloudy clear urine, swollen vein on right foot, abdominal pain, weak and heavy feeling on the face, higher bp than normal, weight loss, weakness on the right leg right arm and left foot, and feels like the circulation is low. This report was non-serious.; Sender''s Comments: V0: Medical Assessment comment was not required as per standard procedure as the case assessed as non-serious.


VAERS ID: 1276499 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Washington  
Vaccinated:0000-00-00
Onset:2021-04-01
Submitted: 0000-00-00
Entered: 2021-05-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN UNKNOWN / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Antibody test, Nausea, Platelet count, Platelet count decreased, Rash
SMQs:, Anaphylactic reaction (broad), Acute pancreatitis (broad), Haematopoietic thrombocytopenia (narrow), Systemic lupus erythematosus (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 3 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Comments: Unknown
Allergies:
Diagnostic Lab Data: Test Date: 202104; Test Name: Antibody test; Result Unstructured Data: Negative; Test Date: 20210420; Test Name: Platelet count; Result Unstructured Data: Low
CDC Split Type: USJNJFOC20210452143

Write-up: LOW PLATELET COUNT; RASH ON LEGS AND FEET WHICH SPREAD TO GROIN AND ABDOMEN; NAUSEA; This spontaneous report received from a consumer (company representative) concerned a male of unspecified age. The patient''s weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, Expiry Date: UNKNOWN) dose was not reported, 1 total, administered on 10-APR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On 19-APR-2021, the patient developed rash on legs and feet. On 20-APR-2021, the rash spread to groin and abdomen. The patient visited the Emergency Room. The patient''s platelet counts were low. There was no thrombosis reported. Patient was admitted to ICU on 20-APR-2021 to investigate about the low platelet counts. On an unspecified date in APR-2021, the patient undergone an antibody test which was found to be negative. IVIG treatment was administered in ICU. The patient got discharged on the 23-APR-2021. The patient was fine. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from low platelet count, rash on legs and feet which spread to groin and abdomen, and nausea on APR-2021. This report was serious (Hospitalization Caused / Prolonged).; Sender''s Comments: V0: 20210452143-Covid-19 vaccine ad26.cov2.s-Low platelet count. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).


VAERS ID: 1276515 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Unknown  
Vaccinated:0000-00-00
Onset:2021-04-01
Submitted: 0000-00-00
Entered: 2021-05-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN - / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Back pain, Pain in extremity, Thrombosis
SMQs:, Retroperitoneal fibrosis (broad), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad), Tendinopathies and ligament disorders (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Comments: Unknown
Allergies:
Diagnostic Lab Data:
CDC Split Type: USJNJFOC20210452841

Write-up: CLOT IN LEGS; ESCALATING PAIN IN LOWER BACK; ESCALATING PAIN IN LEG; This spontaneous report received from a patient via news story concerned a 4 decade (early 40s) male. The patient''s weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, 1 total, administered on 08-APR-2021 for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. In APR-2021, the patient experienced clot in legs and was hospitalized. The patient was improving and scheduled to leave the hospital in few days. On 16-APR-2021, the Patient experienced escalating pain in lower back and leg. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from clot in legs, and the outcome of escalating pain in lower back and escalating pain in leg was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender''s Comments: V0: - Clot in legs (PT-Thrombosis). This event is considered unassessable. The event has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event.


VAERS ID: 1276549 (history)  
Form: Version 2.0  
Age: 58.0  
Sex: Female  
Location: California  
Vaccinated:0000-00-00
Onset:2021-04-23
Submitted: 0000-00-00
Entered: 2021-05-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN UNKNOWN / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Abdominal pain, Blood fibrinogen, Blood homocysteine, Blood immunoglobulin G, Blood immunoglobulin M, Cerebral venous thrombosis, Computerised tomogram, Fibrin D dimer increased, Headache, Immunology test, Jugular vein thrombosis, Mesenteric vein thrombosis, Platelet count, Portal vein thrombosis, Protein C deficiency, Protein S deficiency, SARS-CoV-2 test negative, Splenic vein thrombosis, Thrombocytopenia, Transaminases
SMQs:, Acute pancreatitis (broad), Haematopoietic thrombocytopenia (narrow), Haemorrhage laboratory terms (broad), Systemic lupus erythematosus (broad), Ischaemic central nervous system vascular conditions (narrow), Retroperitoneal fibrosis (broad), Congenital, familial and genetic disorders (narrow), Embolic and thrombotic events, venous (narrow), Thrombophlebitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Ischaemic colitis (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), COVID-19 (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Overweight
Preexisting Conditions: Medical History/Concurrent Conditions: Fatty liver; Comments: The patient had family history significant for a DVT/anticoagulant treatment in her mother, and a history of unspecified blood clots in her maternal grandmother. The patient was on no medications, including no estrogen containing pharmaceutical products or supplements. She has never been exposed to heparin. The patient had no history of COVID-19.
Allergies:
Diagnostic Lab Data: Test Date: 202104; Test Name: ELISA; Result Unstructured Data: Positive; patient had a diagnosis of VITT; Test Date: 202104; Test Name: Platelet count; Result Unstructured Data: 17,000; Test Date: 202104; Test Name: IgM; Result Unstructured Data: against the SARS-COVID-2 nucleocapsid protein-positive; Test Date: 202104; Test Name: IgG; Result Unstructured Data: against the SARS-COVID-2 nucleocapsid protein-positive; Test Date: 202104; Test Name: Transaminases; Result Unstructured Data: Elevated; Test Date: 20210423; Test Name: CT scan; Result Unstructured Data: See relevant lab tests/data; Test Date: 20210423; Test Name: Platelet count; Result Unstructured Data: 22000; Test Date: 20210423; Test Name: COVID-19 virus test negative; Result Unstructured Data: Negative; Test Date: 20210429; Test Name: Platelet count; Result Unstructured Data: 138,000; Test Name: Protein S deficiency; Result Unstructured Data: negative; Test Name: Protein C deficiency; Result Unstructured Data: Negative; Test Name: Homocysteine level; Result Unstructured Data: Negative; Test Name: Fibrinogen; Result Unstructured Data: 103 (low); Test Name: Fibrin D dimer high; Result Unstructured Data: $g12.8 (high); Test Name: CT scan; Result Unstructured Data: Revealed resolution of the sigmoid sinus vein thrombosis; Comments: the internal jugular thrombosis persisted
CDC Split Type: USJNJFOC20210454429

Write-up: LEFT SIGMOID SINUS VEIN THROMBOSIS; PORTAL VEIN THROMBOSIS; SPLENIC VEIN THROMBOSIS; SUPERIOR MESENTERIC VEIN THROMBOSIS; LEFT INTERNAL JUGULAR VEIN THROMBOSIS; THROMBOCYTOPENIA; ABDOMINAL PAIN; HEADACHE; This spontaneous report was received from a physician and concerned a 58-year-old white female. Initial information was received on 27-APR-2021, with additional information obtained via telephone follow up from the physician on 29-APR-2021. The patient''s specific height and weight were not reported. The patient''s past medical history included fatty liver, and the patient was overweight. Family history was significant for a deep venous thrombosis treated with anticoagulants in the patient''s mother, and a history of unspecified blood clots in her maternal grandmother. The patient was on no medications, including no estrogen containing pharmaceutical products or supplements. She has never been exposed to heparin. The patient had no history of COVID-19 infection. The patient received COVID-19 VACCINE AD26.COV2.S (suspension for injection, route of administration not reported, batch number not reported) on 12-APR-2021. The batch number has been requested. No concomitant medications were reported. On 18-APR-2021, 6 days after receiving vaccine, the patient developed a headache. On 23-APR-2021, 11 days after receiving vaccine, the patient presented to the hospital with complaints of headache and abdominal pain. COVID test in the emergency room was negative. On 23-APR-2021, imaging of the head and abdomen revealed: left sigmoid sinus vein thrombosis, portal vein thrombosis, splenic vein thrombosis, superior mesenteric vein thrombosis, left internal jugular vein thrombosis. The patient also had thrombocytopenia, with platelet count on presentation 22,000 (units not provided). D-dimer was elevated at $g12.8 (units not provided), Fibrinogen was low at 103 (units not provided), HIT antibody test by ELISA was positive, and physicians made the diagnosis of Vaccine-induced Thrombotic Thrombocytopenia (VITT). The patient was hospitalized in the intensive care unit. Treatment medications included argatroban, steroids and IVIG. Following treatment, the platelet count remained low, with a nadir of 17,000. On 27-Apr-2021, she underwent thrombectomy and thrombolysis of the intra-abdominal clots. This was performed due to the potential for portal hypertension in the future, given the extent of the thromboses. Repeat CT venogram of the head on an unknown date, revealed resolution of the sigmoid sinus vein thrombosis; the internal jugular thrombosis persisted. The patient has steadily improved since the thrombectomy. Abdominal pain and headache are improving. Platelet count has steadily risen, to 138,000 on 29- Apr-2021. Her transaminases were slightly elevated on admission and have not worsened, and she appears to have no organ dysfunction. A dialysis catheter had been placed in the event she would require plasmapheresis, but this was never used. Additional laboratory data included: IgG and IgM antibodies against the SARS-COVID-2 nucleocapsid protein positive; Protein C deficiency negative; Protein S deficiency negative; Homocysteine level (NR: not provided) negative. Serotonin release assay, anticardiolipin panel and Factor V Leiden tests were pending. The plan was to transition the patient to an oral anticoagulant and remove the dialysis catheter on 30-APR-2021, with a possible discharge on 01-MAY-2021. The patient had not recovered from left sigmoid sinus vein thrombosis, portal vein thrombosis, splenic vein thrombosis, superior mesenteric vein thrombosis, and left internal jugular vein thrombosis, and was recovering from left sigmoid sinus vein thrombosis, thrombocytopenia, headache and abdominal pain. This report was serious (Hospitalization Caused / Prolonged, and Life Threatening). Additional information was received from physician on 29-APR-2021. The following information was updated and incorporated into the case narrative: patient history, disease course, events, outcome, lab data, concomitant drugs.; Sender''s Comments: V0: This spontaneous report concerns a 58-year-old female patient who experienced left sigmoid sinus vein thrombosis, portal vein thrombosis, splenic vein thrombosis, superior mesenteric vein thrombosis, left internal jugular vein thrombosis, thrombocytopenia, headache and abdominal pain, 11 days after receiving COVID-19 VACCINE AD26.COV2.S. The patient is overweight and there is a family history of clots in her mother and maternal grandmother. Imaging of the head and abdomen revealed multiple sites of thrombus formation, platelet count was 22,000, D-dimer was elevated at $g12.8 (units not provided), Fibrinogen was low at 103 (units not provided), and HIT antibody test by ELISA was positive. Physicians made the diagnosis of Vaccine-induced Thrombotic Thrombocytopenia (VITT). The patient was treated with argatroban, IVIG, and steroids. Platelet counts remained low and she underwent thrombectomy of the intra-abdominal thrombi. Following thrombectomy the platelet counts rose and abdominal pain began to improve. Lab data included a positive test for IgG and IgM antibodies against the SARS-COVID-2 nucleocapsid protein. Based on the evolving knowledge of Thrombosis with Thrombocytopenia Syndrome (TTS, per definition from Brighton Collaboration), the low platelet count and temporal relationship to vaccination, we consider the events to have a plausible relationship with vaccination.


VAERS ID: 1276561 (history)  
Form: Version 2.0  
Age: 69.0  
Sex: Male  
Location: Massachusetts  
Vaccinated:0000-00-00
Onset:2021-04-26
Submitted: 0000-00-00
Entered: 2021-05-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 207A21A / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Deep vein thrombosis, Platelet count, Ultrasound Doppler
SMQs:, Embolic and thrombotic events, venous (narrow), Thrombophlebitis (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: ELIQUIS
Current Illness: Sedentary
Preexisting Conditions: Medical History/Concurrent Conditions: Atrial fibrillation (The patient took Eliquis 5mg of Arterial Fibrillation.); Comments: Unknown
Allergies:
Diagnostic Lab Data: Test Date: 202104; Test Name: Duplex ultrasound; Result Unstructured Data: definite clot in right leg; Test Date: 20210427; Test Name: Platelet count; Result Unstructured Data: 167000
CDC Split Type: USJNJFOC20210455157

Write-up: DEEP VEIN THROMBOSIS IN RIGHT LEG (PAIN AND SWELLING); This spontaneous report received from a physician concerned a 69 year old White and not Hispanic or Latino male. The patient''s height, and weight were not reported. The patient''s concurrent conditions included arterial fibrillation, and sedentary lifestyle. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, and batch number: 207A21A expiry: 23-JUN-2021) dose was not reported, frequency 1 total, administered on 11-APR-2021 at left arm for prophylactic vaccination. Concomitant medications included apixaban for chronic atrial fibrillation. It was stated by internist that, on 26-APR-2021, the patient experienced deep vein thrombosis in right leg with symptoms pain and swelling, and was hospitalized on unspecified date. On unspecified date doctor was screening patient for covid-19 infection. On 27-APR-2021, Laboratory data included: Platelet count (NR: not provided) 167000. Laboratory data (dates unspecified) included: Duplex ultrasound (NR: not provided) definite clot in right leg. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of deep vein thrombosis in right leg (pain and swelling) was not reported. This report was serious (Hospitalization Caused / Prolonged, and Other Medically Important Condition).; Sender''s Comments: V0: 20210455157-JANSSEN COVID-19 VACCINE Ad26.COV2.S- Deep vein thrombosis. This event(s) is considered not related. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: MEDICAL HISTORY, UNDERLYING DISEASE.


VAERS ID: 1276571 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Unknown  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-05-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN UNKNOWN / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Migraine, Thrombosis, Vaccination complication
SMQs:, Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Comments: Unknown
Allergies:
Diagnostic Lab Data:
CDC Split Type: USJNJFOC20210455657

Write-up: THROMBOSIS (RED PATCHES ON HANDS, ARMS, LEGS AND FEET); SEVERE MIGRAINES; SEVERE VACCINATION REACTION; This spontaneous report received from a patient via a company representative concerned a 3 decade old male. The patient''s weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown and expiry date: Unknown) dose, 1 total administered, start therapy date was not reported for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. The patient had a severe vaccination reaction, experienced red patches on hands, arms, legs and feet. The patient had visited the hospital and was diagnosed with thrombosis by the physician. Patient was monitored and later discharged. The patient had reattended hospital for severe migraines, also had contacted centers for disease control and prevention regarding vaccination reaction. The patient was unknown for company representative and had only this information. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the thrombosis (red patches on hands, arms, legs and feet), severe migraines and severe vaccination reaction was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender''s Comments: V0.20210455657- COVID-19 VACCINE Ad26.COV2. S -Thrombosis, severe migraines , severe vaccination reaction. This event(s) is considered unassessable. The event(s) has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).


VAERS ID: 1276590 (history)  
Form: Version 2.0  
Age: 45.0  
Sex: Male  
Location: Massachusetts  
Vaccinated:0000-00-00
Onset:2021-04-14
Submitted: 0000-00-00
Entered: 2021-05-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 043A21A / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Chills, Computerised tomogram, Dyspnoea, Hepatic artery thrombosis, Hyperhidrosis, Laboratory test, Splenic thrombosis
SMQs:, Anaphylactic reaction (broad), Neuroleptic malignant syndrome (broad), Embolic and thrombotic events, arterial (narrow), Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Cardiomyopathy (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 1 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Comments: Unknown
Allergies:
Diagnostic Lab Data: Test Date: 20210414; Test Name: Laboratory test; Result Unstructured Data: clot in splenic and celiac artery; Test Date: 20210414; Test Name: CAT scan; Result Unstructured Data: clot in splenic and celiac artery
CDC Split Type: USJNJFOC20210456348

Write-up: CLOT IN SPLENIC ARTERY; CELIAC ARTERY THROMBOSIS; BODY SWEATING; SHORTNESS OF BREATH; CHILLS; This spontaneous report received from a patient concerned a 45 year old male. The patient''s weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 043A21A) dose was not reported, administered to left arm (left deltoid) around 15:00 to 16:00 on 09-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 14-APR-2021, after 5 days of vaccination, in the morning, while driving patient had very severe abdominal pain, very hard time breathing, had to get out of the car because of that, patient thought he was going to die, after 5-10 minutes he felt chills and body was sweating. His wife took him to the hospital on same day. At the hospital unspecified tests and CAT scans were done, and found clot in splenic and celiac artery. Patient was hospitalized on 14-APR-2021 for 1 day and was discharged around 3pm the next day on 15-APR-2021. Patient had another visit with a hematologist on 28-APR-2021 in morning, he found nothing wrong with the body. Patient now had to take Eliquis for 6 months. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills, body sweating, shortness of breath, on APR-2021, and had not recovered from clot in splenic artery, and celiac artery thrombosis. This report was serious (Hospitalization Caused / Prolonged).; Sender''s Comments: V0- 20210456348 - Covid-19 vaccine ad26.cov2.s-clot in splenic artery, and celiac artery thrombosis. These events are considered unassessable. The events have a compatible/suggestive temporal relationship, are unlabeled, and have unknown scientific plausibility. There is no information on any other factors potentially associated with the event.


VAERS ID: 1276626 (history)  
Form: Version 2.0  
Age: 49.0  
Sex: Male  
Location: Unknown  
Vaccinated:0000-00-00
Onset:2021-04-19
Submitted: 0000-00-00
Entered: 2021-05-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN UNKNOWN / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Blood pressure measurement, Body mass index, Body temperature, Deep vein thrombosis, Heart rate, Oxygen saturation, Physical examination, Respiratory rate, Ultrasound Doppler
SMQs:, Embolic and thrombotic events, venous (narrow), Thrombophlebitis (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: ALLEGRA; PRILOSEC [OMEPRAZOLE]; XARELTO
Current Illness: Abstains from alcohol; Marijuana abuse; Non-smoker
Preexisting Conditions: Medical History/Concurrent Conditions: Back surgery; Deep vein thrombosis postoperative (More than 30 years ago); Depression; Heart murmur; Comments: The patient had history of no known allergies. The patient''s mother had a history of aneurysm.
Allergies:
Diagnostic Lab Data: Test Date: 202104; Test Name: Ultrasound Doppler; Result Unstructured Data: subocclusive thrombus within the left common superficial femoral vein; Test Date: 20210421; Test Name: Physical examination; Result Unstructured Data: Abnormal; Test Date: 202104211625; Test Name: Respiratory rate; Result Unstructured Data: 16 /min; Test Date: 202104211625; Test Name: Body temperature; Result Unstructured Data: 98.8 F; Comments: oral temperature; Test Date: 202104211625; Test Name: Pulse rate; Result Unstructured Data: 88; Test Date: 202104211625; Test Name: Oxygen saturation; Result Unstructured Data: 100 %; Test Date: 202104211625; Test Name: Body mass index; Result Unstructured Data: 24; Test Date: 202104211625; Test Name: Blood pressure; Result Unstructured Data: 148/66 mmHg; Test Date: 202104211632; Test Name: Oxygen saturation; Result Unstructured Data: 100 %; Test Date: 202104211632; Test Name: Respiratory rate; Result Unstructured Data: 15; Test Date: 202104211632; Test Name: Body temperature; Result Unstructured Data: 97.8 F; Comments: oral temperature; Test Date: 202104211632; Test Name: Pulse rate; Result Unstructured Data: 91; Test Date: 202104211632; Test Name: Blood pressure; Result Unstructured Data: 148/66 mmHg
CDC Split Type: USJNJFOC20210457179

Write-up: DEEP VEIN THROMBOSIS; This spontaneous report received from a consumer concerned a 49 year old male. The patient''s weight was 80.3 kilograms, and height was 182.9 centimeters. The patient''s past medical history included post-operative deep vein thrombosis (more than 30 years ago), depression, heart murmur, and back surgery, and his concurrent conditions included non-smoker, no alcohol use, and marijuana abuse. The patient had no history of known allergies. The patient''s mother had a history of aneurysm. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown, and expiry date: unknown) dose was not reported, administered on 08-APR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. Concomitant medications included fexofenadine hydrochloride (Allegra) for allergy, rivaroxaban (Xarelto) for venous thromboembolism, and omeprazole (Prilosec) for unknown indication. About one and half weeks after vaccination, on 21-APR-2021, the patient was taken to the emergency department and was admitted with the complaints of leg pain since 2 days with suspected blood clot in leg. Over the last days, patient''s left leg looked swollen compared to the right leg. The patient also had pain, initially started in groin area and radiated down across the anterior portion of the leg, then to posterior leg, and into toes. The patient also had some intermittent tingling in toes. The patient denied of weakness, numbness or persistent paresthesia. The patient was concerned regarding the pain as it felt similar to the post-operative deep vein thrombosis he had in the past. The patient had been anxious since vaccination when hearing about the development of blood clots. The patient also denied of fevers, chills, chest pain, shortness of breath abdominal pain, nausea, vomiting, diarrhea, and difficulty walking. On 21-APR-2021 16:25, the patient''s laboratory data included: Blood pressure (148/66 mmHg), Body mass index (24), Body temperature (98.8 F), Oxygen saturation (100 %) Pulse rate (88), and Respiratory rate (16). On 21-APR-2021 16:32, laboratory data included: Blood pressure (148/66 mmHg), Body temperature (97.8 F), Oxygen saturation (100 %), Pulse rate (91), and Respiratory rate (15). Other general physical examinations included: General: Well-developed well-nourished in no acute distress. HEENT (Head, Eye, Ear, Nose, Throat) examination: normocephalic atraumatic extra ocular motions are intact. Neck examination: Supple without jugular vein distention or meningismus. Lung examination: Clear auscultation bilaterally without wheezes rales or rhonchi. Heart examination: Regular rate and rhythm without murmurs rubs or gallops. Abdomen examination: Soft no tender non-distended without rebound or guarding. Extremities: Without clubbing cyanosis edema, no lacerations or abrasions or ecchymosis noted, no appreciable size difference in the left leg compared to the right, the patient had some tenderness throughout palpation of the medial thigh on the left with radiation up into the left inguinal region, no calf tenderness or swelling, no erythema, palpable posterior tibialis pulse. Skin examination: Warm and dry and well perfused. Psych examination: Appropriate mood and affect. Neuro examination: Cranial nerves 2-12 are grossly intact, strength is 5/5 in upper and lower extremities, full distal sensation in the left lower extremity, full plantar and dorsiflexion of the left foot including the left great toe, sensation is grossly intact, awake, alert and oriented x3. On ultrasound Doppler venous lower extremity test, identified sub occlusive thrombus in the left superficial femoral veins, likely related to organizing/chronic thrombus, however no prior imaging was available at the institution for comparison, no evidence of occlusive deep vein thrombosis. The final diagnosis was made as Deep Vein Thrombosis (DVT). At no time the patient had ever endorsed any chest pain/pleuritic pain, shortness of breath or exertional dyspnea. Due to the nature of this clot, a course of anticoagulation was planned. Patient was prescribed with Xarelto at twice daily starting doses, with transition to 20 mg doses. During the initiation of treatment, the patient should be followed up by his primary care physician for further evaluation. The patient stated that he would call the primary care physician in the following morning for follow-up appointment. The patient was discharged from the hospital on APR-2021. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of deep vein thrombosis was not reported. This report was serious (Hospitalization Caused / Prolonged, and Other Medically Important Condition).; Sender''s Comments: V0: 20210457179-Covid-19 vaccine ad26.cov2.s-deep vein thrombosis. This event is considered not related. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event than the drug. Specifically: MEDICAL HISTORY


VAERS ID: 1276632 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Florida  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-05-01
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN UNKNOWN / UNK - / -

Administered by: Other       Purchased by: ?
Symptoms: Thrombosis
SMQs:, Embolic and thrombotic events, vessel type unspecified and mixed arterial and venous (narrow), Thrombophlebitis (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Comments: Unknown
Allergies:
Diagnostic Lab Data:
CDC Split Type: USJNJFOC20210457363

Write-up: CLOTS; This spontaneous report received from a physician concerned a male of unspecified age. The patient''s weight, height and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration not reported, batch number: Unknown) frequency one total, dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. The physician reported that on an unspecified date, the patient experienced clots. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of clots was not reported. This report was serious (Other Medically Important Condition). This case, from the same reporter is linked to 20210456400.; Sender''s Comments: V0.20210457363-COVID-19 VACCINE AD26.COV2.S -Thrombosis. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).


VAERS ID: 1280599 (history)  
Form: Version 2.0  
Age: 66.0  
Sex: Female  
Location: New York  
Vaccinated:2021-03-08
Onset:2021-04-15
   Days after vaccination:38
Submitted: 0000-00-00
Entered: 2021-05-02
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 1805022 / 1 UN / IM

Administered by: Unknown       Purchased by: ?
Symptoms: Deep vein thrombosis
SMQs:, Embolic and thrombotic events, venous (narrow), Thrombophlebitis (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Factor V Leiden
Allergies: ASA, NSAIDs
Diagnostic Lab Data:
CDC Split Type:

Write-up: Deep venous thrombosis


Result pages: prev   10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28   next

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=19&WRITEUP=thrombosis&VAX=COVID19&VAXTYPES=COVID-19&VAXMAN=JANSSEN

Government Disclaimer on use of this data


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166